The 13th Annual BIO Investor Forum

General Information
Conference Banner: 
Events Banner Image: 
Events Library Thumbnail: 
Conference Start Date: 
October 7, 2014
Conference End Date: 
October 8, 2014
Homepage Center Column Content: 

View the 2013 BIO Investor Forum Program Schedule

>>>Click here to download.<<<

BIO Investor Forum 2013 Media Recap


Meetings Scheduled

Type of Companies

BIOtechNOW Industry Analysis Blog

  • The Return of the Biotech IPO: Blog
  • Forecasted Sales Growth of Top Therapeutic Areas: Anti-Coagulants to Outpace: Blog
  • R&D - Slow Growth Continues: Blog
  • State of the Biotech Industry: Burrill’s Biotech 2013 Report: Blog

Industry News

  • The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts: Article
  • Potential for Deals Drives a Big Surge in the Biotech Sector: Article
  • Seattle biotech Kineta has a plan for faster investor returns: Article
Conference Sidebar Custom: 

Follow BIO Investor Forum
on Twitter, and join the conversation:#BIF14
Join the official LinkedIn Group

Local Co-Host

Supporting Bank Sponsors

Double Helix Sponsors

Helix Sponsors

Conference Sponsors

Media Partners

BIO Investor Forum 
October 7-8, 2014

Thank you for attending the 2013 BIO Investor Forum. See you again in 2014!

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One PartneringTM meetings.

BIO One-on-One PartneringTM provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads. 

BIO Investor Forum Statistics

  • 71% of all U.S. therapeutic companies that have had an IPO in 2013 have attended the BIO Investor Forum at least once in the past four years.
  • Last year’s conference scheduled over 650 meetings.
  • Nearly 80% of all requests were between biotech companies and investors.
  • The event hosted nearly 110 late-stage private and emerging public company presentations.
  • 44% of all U.S. therapeutic IPO companies since 2011 attended BIO Investor Forum as a private company.


Accent Color: 
Calendar Blurb: 
Mark Your Calendar